Financial Performance - Net sales for Q4 2024 decreased by 9.8% to $100.7 million compared to Q4 2023[5] - Gross profit for Q4 2024 was $66.8 million, down 13.0% from $76.8 million in Q4 2023, with a gross profit margin of 66.3%[5] - Adjusted net income for Q4 2024 was $7.6 million, a decrease of 65.8% compared to $22.3 million in Q4 2023[6] - For the fiscal year 2024, net sales decreased by 7.8% to $422.7 million compared to $458.3 million in 2023[8] - The company reported a net income of $19.5 million for fiscal year 2024, down 68.3% from $61.6 million in 2023[8] - Adjusted EBITDA for the year ended December 31, 2024, was $129.665 million, down from $174.260 million in 2023, reflecting a decrease of approximately 25.5%[31] - Net income for the year ended December 31, 2024, was $19.522 million, a decrease of 68.3% compared to $61.587 million in 2023[29] - The company reported a net loss of $8.800 million for Q4 2024, compared to a net income of $14.101 million in Q4 2023[33] Guidance and Projections - Fiscal year 2025 guidance for net sales is projected between $410 million and $431 million, reflecting a decrease from the previous year's actual sales[11] - Adjusted EBITDA margin for fiscal year 2025 is expected to be between 20% and 22%, down from 30.7% in 2024[11] Cash and Assets - As of December 31, 2024, cash and cash equivalents increased to $586.0 million from $466.4 million in 2023[9] - Cash and cash equivalents at the end of 2024 were $585.967 million, up from $466.400 million at the end of 2023, representing a growth of about 25.5%[29] - Total current assets increased to $689.713 million as of December 31, 2024, from $613.196 million in 2023, reflecting an increase of approximately 12.5%[25] Inventory and Liabilities - Inventory at the end of Q4 2024 was $75.2 million, down from $95.9 million at the end of Q4 2023[9] - Long-term debt as of December 31, 2024, was $643.7 million, slightly down from $649.0 million in 2023[9] - Total liabilities decreased slightly to $893.321 million as of December 31, 2024, from $895.370 million in 2023[25] Expenses - Selling, general, and administrative expenses for the year ended December 31, 2024, were $181.685 million, an increase of 7.5% from $168.942 million in 2023[27] - SG&A expenses for Q4 2024 were $52.869 million, up from $49.172 million in Q4 2023, representing a 5.5% increase[33] Other Financial Metrics - Adjusted EBITDA margin for the year ended December 31, 2024, was 30.7%, compared to 38.0% in 2023, indicating a decline of 7.3 percentage points[31] - Adjusted gross profit margin for the year ended December 31, 2024, was 71.4%, unchanged from 2023[31] - Adjusted net income per share for Q4 2024 was $0.01, down from $0.03 in Q4 2023[33] Special Items - The company incurred a one-time payment of $3.5 million to a former distributor in the UAE during 2023 to establish a new partnership[33] - Amortization of intangible assets (excluding software) for the year ended December 31, 2024, was $50.073 million, slightly up from $49.075 million in 2023[33] - The company recorded organizational realignment costs of $2.920 million in Q4 2023[34] - Inventory write-off and disposal costs were incurred due to reformulation of a product, impacting financials in 2023[34] - The company is focused on global reformulation to streamline product offerings in compliance with regulations[34]

NEW YORK, NY, March 04, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ:OLPX) ("OLAPLEX" or the "Company") today announced financial results for the fourth quarter and fiscal year ended December 31, 2024. Amanda Baldwin, OLAPLEX's Chief Executive Officer, commented: "I am pleased with our end to the year with our fourth quarter results ahead of the expectations we shared in November. During 2024 we laid a critical foundation for our business and brand transformation and I remain confident and optimi ...

Core Insights - Olaplex Holdings, Inc. reported financial results for Q4 and fiscal year 2024, indicating a challenging year with significant declines in net sales and profitability [1][2][3]. Financial Performance - Q4 2024 net sales decreased by 9.8% to $100.7 million compared to Q4 2023 [4][5]. - Gross profit for Q4 2024 was $66.8 million, down 13.0% from $76.8 million in Q4 2023, resulting in a gross profit margin of 66.3% [4][5]. - Adjusted net income for Q4 2024 was $7.6 million, a decrease of 65.8% from $22.3 million in Q4 2023 [4][5]. - For the fiscal year 2024, net sales were $422.7 million, down 7.8% from $458.3 million in 2023 [6][5]. - The company reported a net income of $19.5 million for the fiscal year 2024, a decline of 68.3% compared to $61.6 million in 2023 [6][5]. Sales Channel Performance - Specialty Retail sales increased by 5.7% to $28.8 million in Q4 2024, while Professional sales decreased by 27.1% to $31.0 million [5]. - Direct-To-Consumer sales fell by 2.5% to $40.9 million in Q4 2024 [5]. - For the fiscal year 2024, Specialty Retail sales increased by 5.4% to $142.3 million, while Professional sales decreased by 19.3% to $145.3 million [5]. Balance Sheet Highlights - As of December 31, 2024, the company had cash and cash equivalents of $586.0 million, up from $466.4 million a year earlier [7]. - Inventory at the end of Q4 2024 was $75.2 million, down from $95.9 million at the end of 2023 [7]. Fiscal Year 2025 Guidance - The company expects fiscal year 2025 net sales to be between $410 million and $431 million, reflecting a cautious outlook for the first quarter [8][9]. - Adjusted gross profit margin for fiscal year 2025 is projected to be between 70.5% and 71.5% [9]. Company Overview - Olaplex is a health and beauty company known for its innovative hair care products, leveraging its Complete Bond Technology™ to enhance hair health [12].

Core Insights - Olaplex Holdings, Inc. (OLPX) is expected to report break-even quarterly earnings per share, reflecting a 100% decline compared to the same period last year [1] - Analysts forecast revenues of $87.6 million for the quarter, indicating a year-over-year decrease of 21.6% [1] - The consensus EPS estimate has remained unchanged over the last 30 days, suggesting stability in analysts' reassessments [1] Revenue Projections - Analysts estimate 'Revenue- Professional' will reach $29.54 million, a decrease of 30.5% from the prior-year quarter [4] - 'Revenue- DTC' is projected at $34.43 million, reflecting an 18% year-over-year decline [4] - The consensus for 'Revenue- Specialty retail' is $23.51 million, indicating a change of -13.9% year over year [4] Stock Performance - Over the past month, Olaplex shares have recorded a return of -3.9%, compared to a -2.2% change in the Zacks S&P 500 composite [5] - Based on its Zacks Rank 3 (Hold), Olaplex is expected to perform in line with the overall market in the upcoming period [5]

Company Participation - Olaplex Holdings, Inc. will participate in the Raymond James 46 Annual Institutional Investors Conference on February 26, 2025 [1] - The presentation will be hosted by Amanda Baldwin, CEO, and Catherine Dunleavy, COO and CFO, on March 5, 2025, at 9:50 am ET [2] Company Overview - Olaplex is a health and beauty company founded in 2014, known for its innovative hair care products [3] - The company revolutionized the prestige hair care market with its Complete Bond Technology™, which protects and strengthens hair during and after services [3] - Olaplex offers a full suite of hair health formulas and sells its products globally through various channels, including professional, specialty retail, and direct-to-consumer [3]

Company Overview - Olaplex Holdings, Inc. is a technology-driven beauty company focused on improving hair health through innovative bond-building technology [3] - The company revolutionized the prestige hair care category in 2014 by creating products that protect, strengthen, and relink broken hair bonds [3] - Olaplex's proprietary ingredients operate on a molecular level to repair damaged hair, and its products are sold through an expanding omnichannel model [3] Upcoming Financial Results - The company plans to report its fourth quarter and fiscal 2024 financial results on March 4, 2025, before the market opens [1] - An investor conference call and webcast will be held on the same day at 9:00 am ET/6:00 am PT to review the financial results [2] - The webcast will be accessible on the company's investor relations website, and a replay will be available for 90 days [2]

Olaplex Holdings, Inc. (NASDAQ: OLPX ) delivered impressive financial performance from 2020 to 2023, and many business drivers indicate further business growth. New investments in the Lashbond Building Serum Market, expansion of distribution agreements all over the world, and newLike the common kingfisher or Alcedo Atthis searches for small fish, I research small, and medium cap companies in Europe, the United States, and South America. You can find a common kingfisher in my profile.With close to 14 years i ...

Financial Data and Key Metrics Changes - The company reported third quarter net sales of $119.1 million, a decline of 3.6% year-over-year, although this represented sequential improvement from Q2 [8][40] - Adjusted EBITDA was $44.6 million, with an adjusted EBITDA margin of 37.5%, down from 41.7% a year ago [8][45] - The company revised its fiscal year 2024 guidance, now expecting net sales in the range of $405 million to $415 million, down from the previous range of $435 million to $463 million [9][48] Business Line Data and Key Metrics Changes - Specialty retail sales decreased by 1.3% year-over-year to $42.6 million, reflecting increased competitive intensity [41] - Professional channel net sales fell by 12.6% year-over-year to $42.2 million, primarily due to weaker international demand [41] - Direct-to-consumer sales increased by 6.8% year-over-year to $34.3 million, driven by strong sell-in ahead of a major customer promotion [42] Market Data and Key Metrics Changes - The international business underperformed expectations, leading to a revision in guidance [8][49] - The U.S. market showed consistent sell-through trends at key accounts, but overall demand lift from new marketing investments has not yet materialized [40][50] Company Strategy and Development Direction - The company is focusing on a transformation strategy for 2024, prioritizing long-term health and building a stronger foundation [9][10] - Key strategic initiatives include maximizing sales and marketing investments, strengthening capabilities and culture, and developing a long-term roadmap [21][34] - The company is rationalizing its international distributor network to enhance brand equity and streamline operations [14][62] Management's Comments on Operating Environment and Future Outlook - Management acknowledged that the beauty market remains healthy but highly competitive, with expectations of increased promotional activity during the holiday season [19][20] - The company is optimistic about its brand strength and the potential for future growth despite current challenges [11][36] - Management emphasized the importance of marketing investments for long-term success and brand positioning [20][55] Other Important Information - The adjusted gross profit margin improved to 70.8%, up 110 basis points from the previous year, driven by favorable inventory management [43] - The company ended the third quarter with $538.8 million in cash and cash equivalents, indicating strong cash generation capabilities [47] Q&A Session Summary Question: Insights on overall consumer health and international business - Management noted that salon visits have not changed significantly, and there is a need to support stylists to encourage more frequent visits [59] - The enthusiasm for the brand remains strong internationally, but closer partnerships with distributors are necessary for better market penetration [61][62] Question: Expectations for marketing efforts to yield results - Management indicated that while new product launches are showing promise, a broader lift across the entire portfolio is still needed [63][64] Question: Impact of international realignment on sales - International business is the primary driver of the revised fourth quarter guidance, with expectations for stabilization in the future [67][68] Question: Cost structure and SG&A guidance - Management confirmed that continued investment in marketing is essential, even as SG&A expenses are expected to rise [71][72] Question: Competitive landscape and consumer confusion - Management acknowledged the need for clearer communication of the brand's unique science and efficacy to combat consumer confusion [87][89]

Table of Contents Large Accelerated Filer ☐ Accelerated Filer ☒ Non-accelerated Filer ☐ Smaller reporting company ☐ Emerging growth company ☐ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________ FORM 10-Q ________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O ...

Olaplex Holdings, Inc. (OLPX) reported $119.08 million in revenue for the quarter ended September 2024, representing a year-over-year decline of 3.6%. EPS of $0.04 for the same period compares to $0.05 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $125.43 million, representing a surprise of -5.06%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.04.While investors closely watch year-over-year changes in headline numbers -- revenue and earnin ...